… A retrospective observational study of nonvalvular atrial fibrillation patients initiating apixaban,
dabigatran, rivaroxaban, or warfarin from January 1, 2013, to September 30, 2015, was …

… Therefore, the objective of the current study was to assess the safety, effectiveness, and
continued use (ie medication persistence) of rivaroxaban and warfarin in patients with …

Background and Objective Atrial fibrillation (AF), the most common cardiac arrhythmia,
typically increases with age. Oral anticoagulants (OACs) are the cornerstone of treatment to …

… reviewed and meta-analyzed observational studies assessing the comparative
effectiveness and safety of DOACs for stroke prevention in patients with atrial fibrillation (AF). …

Catheter ablation is a promising therapy for atrial fibrillation (AF), but its utility in patients with
left ventricular systolic dysfunction (LVSD) is uncertain. The objectives of this study were to …

… to evaluate both effectiveness and safety. Sixth, this study only included treatment-naïve
apixaban and warfarin patients because a comparison between patients who switched from …

Objectives To assess the risk of stroke/systemic embolism (SE) and major bleeding associated
with the use of oral anticoagulants in elderly patients with atrial fibrillation (AF) in a real-…

… The inclusion and exclusion criteria of this study yielded over 466,000 patients with nonvalvular
atrial fibrillation, of which 40,271 had active cancer. These patients were matched into …

… acute-onset atrial fibrillation (AAF) is widely performed in the emergency department (ED).
The aim of this study was to describe the effectiveness and safety of electrical cardioversion of …

Objective: To compare the risk of stroke/systemic embolism (S/SE) and major bleeding (MB)
of elderly (≥65 years of age) nonvalvular atrial fibrillation (NVAF) patients initiating …